Czech/SlovakiaCzech RepublicSlovakia

US Agri-Giant Awaits First TimeClearance for GM Seeds in Europe

16.09.2003

Prague - The Czech Ministry of Environment has postponed a decision on the application by US agriculture giant Monsanto Corp. for clearance for so-called 'Bt Maize' for commercial production until an expert commission gives its opinion. Monsanto, the world's largest supplier of GM seeds, is the first company to ask Czech authorities to approve commercial production of GM seeds - no European country has done this so far. The Bt Maize strain has the advantage of being toxic to the European corn borer, a common pest of the maize crop.
Currently Monsanto only grows this strain of maize experimentally in the Czech Republic at Branisovice, in South Moravia. The Czech Minister for the Environment Libor Ambrozek was originally expected to rule on the Monsanto application by the end of June but handed over the documents to the expert panel in July (see also page 36). According to government sources it is uncertain how long the commission could take to report back and when a final decision could be expected.
In the Czech Republic all food products containing GMOs must, according to new case-law since January 1, 2002, be cleared by the Ministry of Health. The products themselves must be labelled as “genetically modified” or containing “genetically-modified organisms”. More food made from genetically modified crops could be on the way following the July 2 decision of the European Parliament to drop its five-year ban on the introduction of new biotech products on the European Union (EU) market and allow GM foods into the EU as long as they are clearly labelled.
The Bt-toxin, a protein which is naturally expressed in the soil bacterium Bacillus thuringiensis, has the ability to destroy the intestinal wall of different varmints without harmfull side-effects for beneficial organisms. In humans most isoforms of Bt-toxin are non-toxic and digested very early in the gastro-intestinal tract. Only one Bt-toxin variant, called Cry9c, is suspected to cause allergic reactions. Back in September 2000 Cry9c-containing StarLinkTM corn by former Aventis CropScience caused a food scandal when it was found in the human food supply despite having been approved for animal feed use only.
Monsanto began field trials in the Czech Republic in August 2001 using herbizide resitant Roundup Ready wheat. While according to Czech media reports public support for the new technology was more widespread in the Czech Republic at that time than in other European countries, the Monsanto trial had aggravated the discussion. Especially Greenpeace objected to the trials. The environmentalists argued that Monsanto's wheat was likely to contaminate regular grown crops threatening the country's wheat export.

Czech/SlovakiaCzech RepublicSlovakia

01.02.2010

Prague – After increasing its investment in mid-January, full-service provider CRO FGK Clinical Research GmbH has become a major shareholder in the Czech contract research organization Avemedica s.r.o. Financial details were not...

Czech/SlovakiaCzech RepublicSlovakia

01.02.2010

Pilzen – German antibody drug development and discovery firm Affimed Therapeutics AG (Heidelberg) has spun-out all of its antibody discovery activities into a new Czech subsidiary – AbCheck s.r.o., which is located in Pilzen....

Czech/SlovakiaCzech RepublicSlovakia

18.09.2009

Prague/Jena – German and Czech researchers under Ales Svatos have opened the door to major improvements in the application of high-throughput metabolomics and systematic analyses of small molecules via MALDI-mass spectrometry...

Czech/SlovakiaCzech RepublicSlovakia

19.07.2009

Ceské Budejovice - The scientists from the Biology Centre of the Czech Academy of Science who coordinated the EU project MOBITAG have tabled a report on their attitudes towards political interference in the EU’s GMO authorisation...

Czech/SlovakiaCzech RepublicSlovakia

14.07.2009

Bratislava – According to a new study released by PG Economics, Slovak farmers would benefit more than counterparts in other EU countries from planting genetically-engineered Bt maize. Regional factors, as well as reducing an...

Czech/SlovakiaCzech RepublicSlovakia

14.07.2009

Vestec – The Czech Academy of Sciences and Charles University plan to build a modern biotechnology and biomedicine center, according to reports issued by the Czech Information Agency. With about 40,000 square meters of floor...

Czech/SlovakiaCzech RepublicSlovakia

13.07.2009

Olomouc – A new cluster with a focus on drug development and diagnostics has been established near Palacky University in Olmouc. Called MedChemBio, the centre seeks to attract companies with an interest in medicinal and...

Czech/SlovakiaCzech RepublicSlovakia

12.07.2009

Prague – A biotech company and a pharmaceutical enterprise are the winners of this year’s “Investor of the Year” competition, which is organised by CzechInvest and the country’s Association for Foreign Investment. At the end of...

Czech/SlovakiaCzech RepublicSlovakia

29.04.2009

Prague – A2Z Bio, the Czech subsidiary of UK-based Yorkshire Bioscience, is investing EUR100,000 at the CKD Prague Technological Innovation Centre to launch production of research reagents and services for the biotech R&D market....

Displaying results 11 to 20 out of 70

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-czech-slovakia/browse/1/article/us-agri-giant-awaits-first-timeclearance-for-gm-seeds-in-europe.html

Events

All Events

Stock list

All quotes

TOP

  • MOLOGEN7.85 EUR5.65%
  • CYTOS0.26 CHF4.00%
  • PAION2.48 EUR2.06%

FLOP

  • 4SC1.25 EUR-2.34%
  • FORMYCON6.75 EUR-1.75%
  • VITA 343.75 EUR-1.57%

TOP

  • SANTHERA83.50 CHF27.5%
  • BB BIOTECH140.45 EUR6.3%
  • HBM86.00 CHF3.7%

FLOP

  • MOLOGEN7.85 EUR-17.4%
  • WILEX2.36 EUR-15.7%
  • MEDIGENE4.48 EUR-12.5%

TOP

  • SANTHERA83.50 CHF3695.5%
  • CO.DON2.61 EUR226.2%
  • PAION2.48 EUR185.1%

FLOP

  • CYTOS0.26 CHF-93.5%
  • MEDIGENE4.48 EUR-67.4%
  • THERAMETRICS0.08 CHF-42.9%

No liability assumed, Date: 27.08.2014


Current issue

All issues

Product of the week

Products